logo-bullish-stock-alerts
  • About
    • FAQ
    • Client Reviews
    • Pricing
  • Contact
  • Investment portfolios
  • Blog
    • Investing Strategies
    • Market News
    • Cryptocurrency News
    • Investing Tools and Regulations
  • Login
    • My Account
    • Invoices
    • Edit Profile
Join our free newsletter!

Amazon (AMZN):Tech Giant Reinventing Profitability

by Oswald MANEGDO ARIELLE SAWADOGO | Dec 24, 2025 | Market News

Amazon is not just an e-commerce titan. It is also the global cloud leader (AWS), a logistics empire, and a dominant force in AI and advertising. After years of profitability pressure, Amazon is back with impressive earnings and a rebound in margins. However, despite...

AMD Blows Past Margin Expectations in 2025: Should You Buy Before the Next AI Rally?

by Oswald MANEGDO ARIELLE SAWADOGO | Dec 24, 2025 | Market News

Full analysis and key alerts so you don’t miss the breakout. AMD remains a cornerstone in the semiconductor industry, known for its Ryzen and EPYC x86 CPUs and Radeon GPUs. The company stands at the intersection of several megatrends: AI, data centers, gaming, and...

AMAT: the discreet king of global technological infrastructure

by Oswald MANEGDO ARIELLE SAWADOGO | Dec 24, 2025 | Market News

Applied Materials is the technological backbone of the global semiconductor industry, manufacturing the essential tools used to fabricate chips for giants like NVIDIA, TSMC, Intel, and others.In 2025–2026, AMAT showcases strong profitability, operational control, and...

Abbott Laboratories (ABT): Is This Medical Giant Still Flying Under the Radar?

by Oswald MANEGDO ARIELLE SAWADOGO | Dec 22, 2025 | Market News

Abbott Laboratories is one of the world’s leading healthcare companies, specializing in: Medical devices (pacemakers, FreeStyle Libre glucose monitors) Medical nutrition (Ensure, Pedialyte) Diagnostics (laboratory and COVID-19 tests) Generic pharmaceuticals Present in...

AbbVie (ABBV) 2026: Strong Yield, but at What Cost?

by Oswald MANEGDO ARIELLE SAWADOGO | Dec 22, 2025 | Market News

AbbVie, a global pharmaceutical powerhouse, continues to grow while maintaining solid margins and strong free cash flow. However, a sharp drop in net income in 2025 (TTM) and a stretched valuation raise doubts. The Humira era is coming to an end, and transitioning to...
« Older Entries
Next Entries »

Read more Investment Insights for Free


Explore Investment Categories

  • Cryptocurrency News
  • Investing Strategies
  • Investing Tools and Regulations
  • Investment Insights
  • Market News

Recent Market Alerts & Analysis

  • MA (Mastercard) at $509: the “margin machine” pulling back… before a potential breakout to new highs 🚀
  • LRCX (Lam Research) at $260.96: the “hidden king of semiconductors” the market is starting to reprice… before (possibly) a golden entry point at $240–225 🚀
  • Strait of Hormuz Shock: Why This Oil Crisis Could Ignite Energy, Tanker and Defense Stocks ?
  • KO (Coca-Cola) at $80.56 near all-time highs: the market is pricing it as “risk-free”… until the $68–$72 pullback window reopens
  • IBM (International Business Machines Corp)


Address

300 Park Avenue, 12th Floor New York, NY 10022, United States

}

Business hours

Open 24 hours from Monday to Sunday

Legal Notice

  • *Terms and conditions of sale
  • Privacy policy
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
  • FollowFollow
Copyright © 2026 Bullish Stock Alerts. All Rights Reserved.